Clinical trial
Evaluation of Alternative Oseltamivir (Tamiflu) Dosing Strategies.
NCT00304434 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00304434 |
|---|---|
| Title | Evaluation of Alternative Oseltamivir (Tamiflu) Dosing Strategies. |
| Official title | Oseltamivir (Tamiflu) Dosing Strategies for Use During Influenza Prophylaxis (VA01) |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Collaborators | Brooke Army Medical Center U.S. Fed National Institutes of Health (NIH) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Drug |
| Interventions | Oseltamivir, Probenecid |
| Enrollment | 48 |
| Start date | Feb 1, 2005 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Mar 17, 2006 |
| Last update posted | Sep 23, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: